KDNY - Chinook Therapeutics GAAP EPS of -$0.54 beats by $0.11 revenue of $2.7M May, 12 2022 05:06 PM Chinook Therapeutics Inc Com Chinook Therapeutics press release (NASDAQ:KDNY): Q1 GAAP EPS of -$0.54 beats by $0.11. Revenue of $2.7M (+671.4% Y/Y). For further details see: Chinook Therapeutics GAAP EPS of -$0.54 beats by $0.11, revenue of $2.7M